What the FDA labels say about taking them together
Oxaliplatin and panitumumab
Panitumumab's FDA label of June 23, 2026 names oxaliplatin in its warnings and precautions section; the oxaliplatin label PlainMeds reads does not name panitumumab. The panitumumab label: “As a result of the toxicities experienced, patients randomized to Vectibix, bevacizumab, and chemotherapy received a lower mean relative dose intensity of each chemotherapeutic agent over the first 24 weeks on study …”
Check it at the source: the oxaliplatin FDA label on DailyMed (effective August 24, 2026, Gland Pharma Limited); the panitumumab FDA label on DailyMed (effective June 23, 2026, Amgen, Inc).
What does the oxaliplatin label say about panitumumab?
Oxaliplatin's label (effective August 24, 2026) does not name panitumumab in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Oxaliplatin), Gland Pharma Limited, effective August 24, 2026 (SPL set a6f89dc3-a594-4b5b-8728-272e20c1ecb5), via openFDA; the full label on DailyMed
What does the panitumumab label say about oxaliplatin?
Panitumumab label, warnings and precautionsAs a result of the toxicities experienced, patients randomized to Vectibix, bevacizumab, and chemotherapy received a lower mean relative dose intensity of each chemotherapeutic agent (oxaliplatin, irinotecan, bolus 5-FU, and/or infusional 5-FU) over the first 24 weeks on study compared with those randomized to bevacizumab and chemotherapy.
Source: FDA drug label (Vectibix), Amgen, Inc, effective June 23, 2026 (SPL set e0fa4bca-f245-4d92-ae29-b0c630a315c2), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Oxaliplatin | Panitumumab | |
|---|---|---|
| Labeled for | Colorectal cancer | Colorectal cancer |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once